<i>GRIN2A</i> mutation and early‐onset epileptic encephalopathy: personalized therapy with memantine

Abstract

This case exemplifies the potential for personalized genomics and therapeutics to be utilized for the early diagnosis and treatment of infantile-onset neurological disease.